Einstein proved energy hides in mass.
We prove value hides in your portfolio.
Value creation is no longer only about growth. It is about proof.
Across private markets, net TVPI has risen for six consecutive quarters while DPI has stayed flat. That dynamic increases the importance of portfolio companies that can clearly demonstrate operational maturity, risk readiness, compliance discipline, and a credible path to scalable value.
ChronoProof equips healthcare-focused PE and VC firms with a systematic way to surface portfolio friction, benchmark readiness, and build the evidence that matters in diligence, financing, insurance, strategic partnerships, and exit.
VC¹ — today
Capital + Network. Distributions near GFC-era lows as a share of NAV. Holds past year eight. Value leaks where deals wait.
The multiplier
The J-curve: negative early net performance from capital calls, fees and early write-downs, turning positive as companies are realized.
VC² — squared
(Capital + Network) × Proof × Benchmarking against similar funds and similar companies with "Insurability Ready" portfolio risk views.
The five products are the exponent
Most PE or VC funds run on the first power — capital plus network or capital plus operating playbook. Linear. Additive. ChronoProof closes the proof gap and turns the line into a curve.
PE¹ — today
Capital + Operating Playbook. Longer holds, higher financing costs, and uneven execution make operational and risk friction a direct threat to EBITDA and exit value.
The multiplier
The value-creation gap: Entry price and leverage set the deal. Operating improvement, proof, and risk readiness determine whether the value is realized.
PE² — squared
(Capital + Operating Playbook) × Proof × Benchmarking against comparable companies, with “Insurability Ready” risk views built for diligence, financing, and exit.
Weeks of research compress into hours
Measured against 30+ hour manual evaluation across 45 sources
Five products. One intelligence infrastructure.
ChronoSuite delivers all five products from one integrated layer. Or you can choose which individual products you would like.
ChronoScout
Proprietary deal flowTransform deal-flow economics. An AI deal engine pulling from regulatory, clinical, and commercial data.
Watch the filmChronoTruth
comparability axis across the portfolioPortfolio GRC, quantified. Turn Azure complexity into clear, defensible, comparable maturity signals.
Watch the filmChronoSee
portfolio monitoring, regulatory dimensionCyber, on the same footing as financials. Quarterly portfolio-wide risk visibility in under one hour.
Watch the filmChronoPulse
DPI, TVPI and vintage, normalizedYour fund's intelligence layer. Three signals — Scout, Truth, See — unified into one view of portfolio health.
Watch the filmChronoCurve
Exit window, MOIC and DPI impactExit strategy, repeatable. Move from "we think it's time" to "here's why — right now."
Watch the filmConcierge
Our discovery assetIt's how we discover exactly what you want and need in our ChronoProof platform. A strategic partner in how we help you source, manage, and exit.
Watch the filmOne product. One company. One clear proof of value.
Lets start at the wedge - one ChronoProof product on one deal flow; sourcing with Scout, portfolio management with Pulse, Cloud security with Truth, exit value and timing with Curve
We deploy it to prove the value; quality, clarity, alerting and triggers.